Survival in Myeloblastic Leukemia of Adults

Publisher Website
Google Scholar
Abstract
SURVIVAL in myeloblastic leukemia of adults has not appreciably changed since the advent of chemotherapy. As pointed out by Gunz et al.,1 the progress of the disease may be quite variable, but it usually follows a rapidly downhill course, with death ensuing within several weeks to months. A few patients, however, may live in apparent symbiosis with their disease for periods of up to several years. These cases, unfortunately, are uncommon. Recently, several reports have appeared suggesting that aggressive chemotherapy with combinations of agents may prolong life in this disease.2 3 4 To evaluate these studies in the light of our own . . .

This publication has 1 reference indexed in Scilit: